Studies report an increased expression of the NLRP3 and IL‐1β genes in the brains and cerebrospinal fluid (CSF) of MS patients, as well as elevated levels of ASC, caspase‐1, and IL‐18 in serum [48, 49]. This evidence concerns the gene IL18 and myeloid sarcoma.